Catherine Snaith

Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)

Catherine Snaith, David Thickett, Lucie Linhartová et al. · Critical Care · 2012 · 138 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +11

Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome

Simon Gates, Charlotte Kelly, Duncan Young et al. · Health Technology Assessment · 2013 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Clinical review: Probiotics in critical care

Neil Crooks, Catherine Snaith, Deborah Webster et al. · Critical Care · 2012 · 31 citations · Full text

Life Sciences, Immunology, Microbiology +14

Atorvastatin for preventing the progression of sepsis to severe sepsis (ASEPSIS Trial): a randomised, double-blind, placebo-controlled trial (ISRCTN64637517)

JM Patel, Catherine Snaith, David Thickett et al. · Critical Care · 2011 · 15 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +11